| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | Purified recombinant human IFN-gamma was used as the immunogen for the Interferon gamma antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
Interferon gamma Antibody is an antibody targeting Interferon. Host: Mouse. Monoclonal. Clone: IFNG/464. Format: Purified. Applications: FACS, IF.
Key elements and design rationale
- Target: Interferon.
- Immunogen: Purified recombinant human IFN-gamma was used as the immunogen for the Interferon gamma antibody..
- Species reactivity: Human.
- Localization: Cytoplasm, Extracellular (secreted).
- Conjugate: Unconjugated (no label listed).
Biological background (from provided description)
Recognizes a protein of 20-25kDa, identified as human interferon. This mAb is specific to human IFN-gamma and recognizes both recombinant and native human IFN-gamma. T lymphocytes and NK cells mainly produce IFN-gamma.
Common research applications
- IF/ICC: subcellular localization imaging with proper background controls.
Notes for experimental interpretation
- Account for isoforms, paralogs, and post-translational modifications when interpreting signal.
- Support specificity with biological controls (e.g., KO/KD where available) and technical controls (e.g., secondary-only/isotype).
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
